A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) (ROCKET-Ignite)

April 17, 2024 updated by: Amgen

A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD)

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.

Study Overview

Status

Recruiting

Conditions

Atopic Dermatitis

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

700

Phase

Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Amgen Call Center
Phone Number: 866-572-6436
Email: medinfo@amgen.com

Study Locations

Argentina
- Buenos Aires
  - Caba, Buenos Aires, Argentina, C1027AAP
    - Recruiting
    - Cinme - Centro de Investigaciones Metabolicas
  - Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1426ABP
    - Recruiting
    - Fundación Respirar
  - Derqui, Pilar, Buenos Aires, Argentina, B1629ODT
    - Recruiting
    - Hospital Universitario Austral
  - San Miguel, Buenos Aires, Argentina, 1663
    - Recruiting
    - Centro Dermatologico Schejtman
- Distrito Federal
  - Caba, Distrito Federal, Argentina, C1012AAY
    - Recruiting
    - Conexa Investigacion Clinica SA
  - Ciudad Autonoma de Buenos Aires, Distrito Federal, Argentina, 1425
    - Recruiting
    - Instituto de Neumonologia y Dermatologia
  - Ciudad Autonoma de Buenos Aires, Distrito Federal, Argentina, 1425
    - Recruiting
    - InAER - Investigaciones en Alergia y Enfermedades Respiratorias
- Santa Fe
  - Rosario, Santa Fe, Argentina, 2000
    - Recruiting
    - Fundacion Estudios Clinicos
  - Rosario, Santa Fe, Argentina, 2000
    - Recruiting
    - Instituto de Diagnostico Abc American British Cowdray
Brazil
- - Rio de Janeiro, Brazil, 20241-180
    - Recruiting
    - IBPClin Instituto Brasil de Pesquisa Clinica
  - São Paulo, Brazil, 06454-010
    - Recruiting
    - Alergoalfa Nucleo Diagnostico Tratamento e Pesquisa Clinica em Alergia
- Rio Grande Do Sul
  - Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903
    - Recruiting
    - Hospital de Clínicas de Porto Alegre
  - Porto Alegre, Rio Grande Do Sul, Brazil, 90160-093
    - Recruiting
    - Hospital Ernesto Dornelles
- São Paulo
  - Botucatu, São Paulo, Brazil, 18618-686
    - Recruiting
    - Upeclin-Pesq Clin FacMed Botucatu
  - Santo Andre, São Paulo, Brazil, 09060-870
    - Recruiting
    - Fundacao Abc - Centro Univ Fmabc
  - Santo Andre, São Paulo, Brazil, 09030-010
    - Recruiting
    - Hosp e Maternidade Dr Christovao da Gama
  - Sorocaba, São Paulo, Brazil, 18040-425
    - Recruiting
    - Consultoria Medica e Pesquisa Clinica Cmpc
Canada
- - Quebec, Canada, G1G 3Y8
    - Recruiting
    - Recherche Clinique Sigma Incorporated
- Alberta
  - Edmonton, Alberta, Canada, T6G 1C3
    - Recruiting
    - Alberta Derma Surgery Centre
  - Edmonton, Alberta, Canada, T6H 4J8
    - Recruiting
    - Vida Clinical Research
- Ontario
  - Ajax, Ontario, Canada, L1S 7K8
    - Recruiting
    - CCA Medical Research Corporation
  - Barrie, Ontario, Canada, L4M 7G1
    - Recruiting
    - SimcoDerm Medical and Surgical Dermatology Centre
  - Hamilton, Ontario, Canada, L8L 3C3
    - Recruiting
    - Leader Research
  - Mississauga, Ontario, Canada, L4Y 4C5
    - Recruiting
    - DermEdge Research Incorporated
  - North York, Ontario, Canada, M3B 0A7
    - Recruiting
    - Canadian Dermatology Centre
  - North York, Ontario, Canada, M3B 3S6
    - Recruiting
    - Gordon Sussman Clinical Research Incorporated
  - Richmond Hill, Ontario, Canada, L4E 4L6
    - Recruiting
    - Oak Ridges Aesthetics Centre
- Quebec
  - Montreal, Quebec, Canada, H2X 2V1
    - Recruiting
    - Innovaderm Research Inc
- Saskatchewan
  - Saskatoon, Saskatchewan, Canada, S7K 2C1
    - Recruiting
    - Skinsense Medical Research
China
- - Beijing, China, 100044
    - Recruiting
    - Peking University Peoples Hospital
  - Shanghai, China, 200443
    - Recruiting
    - Shanghai skin disease hospital
- Beijing
  - Beijing, Beijing, China, 100191
    - Recruiting
    - Peking University Third Hospital
  - Beijing, Beijing, China, 100050
    - Recruiting
    - Beijing Friendship Hospital, Capital Medical University
- Fujian
  - Fuzhou, Fujian, China, 350000
    - Recruiting
    - The First Affiliated Hospital Of Fujian Medical University
- Guangdong
  - Guangzhou, Guangdong, China, 510091
    - Recruiting
    - Dermatology Hospital of Southern Medical University
  - Guangzhou, Guangdong, China, 510120
    - Recruiting
    - Sun Yat-Sen Memorial Hospital Sun Yat-sen University
  - Guangzhou, Guangdong, China, 510080
    - Recruiting
    - The First Affiliated Hospital ,Sun-Yat Sen University
- Hebei
  - Shijiazhuang, Hebei, China, 050000
    - Recruiting
    - The First Hospital of Hebei Medical University
- Henan
  - Nanyang, Henan, China, 473002
    - Recruiting
    - Nanyang First Peoples Hospital
  - Sanmenxia, Henan, China, 472099
    - Recruiting
    - Sanmenxia Central Hospital
- Hubei
  - Wuhan, Hubei, China, 430022
    - Recruiting
    - Union Hospital Tongji Medical College Huazhong University of Science and Technology
- Hunan
  - Changsha, Hunan, China, 410011
    - Recruiting
    - The Second Xiangya Hospital Of Central South University
- Jiangsu
  - Jiangyin, Jiangsu, China, 214400
    - Recruiting
    - Jiangyin Hospital of Traditional Chinese Medicine
  - Wuxi, Jiangsu, China, 241023
    - Recruiting
    - Wuxi Peoples Hospital
- Jiangxi
  - Nanchang, Jiangxi, China, 330000
    - Recruiting
    - Dermatology Hospital of Jiangxi Province
- Jilin
  - Changchun, Jilin, China, 130021
    - Recruiting
    - The First Hospital of Jilin University
- Liaoning
  - Shenyang, Liaoning, China, 110001
    - Recruiting
    - The First Hospital of China Medical University
- Sichuan
  - Chengdu, Sichuan, China, 610021
    - Recruiting
    - Chengdu Second Peoples Hospital
- Zhejiang
  - Hangzhou, Zhejiang, China, 310003
    - Recruiting
    - The First Affiliated Hospital Zhejiang University School of Medicine
  - Hangzhou, Zhejiang, China, 310020
    - Recruiting
    - Affiliated Hangzhou First Peoples Hospital，Zhejiang University School of Medicine
  - Hangzhou, Zhejiang, China, 310004
    - Recruiting
    - Zhejiang Provincial Peoples Hospital
  - Taizhou, Zhejiang, China, 318000
    - Recruiting
    - Taizhou Central Hospital
Croatia
- - Ivanic-Grad, Croatia, 10310
    - Recruiting
    - Special Hospital for Medical Rehabilitation Naftalan
  - Zagreb, Croatia, 10000
    - Recruiting
    - University Hospital Centre Zagreb
  - Zagreb, Croatia, 10000
    - Recruiting
    - Sestre milosrdnice University Hospital Center
Czechia
- - Nachod, Czechia, 547 01
    - Recruiting
    - Dermamedica, sro
  - Ostrava, Czechia, 702 00
    - Recruiting
    - CCR Ostrava sro
  - Pardubice, Czechia, 530 02
    - Recruiting
    - Pratia Pardubice as
  - Praha 10, Czechia, 100 00
    - Recruiting
    - Clintrial sro
  - Praha 3, Czechia, 130 00
    - Recruiting
    - Pratia Prague sro
  - Praha 8, Czechia, 180 81
    - Recruiting
    - Fakultni nemocnice Bulovka
  - Usti nad Labem, Czechia, 401 13
    - Recruiting
    - Krajska zdravotni as - Masarykova nemocnice Usti nad Labem oz
Germany
- - Berlin, Germany, 10117
    - Recruiting
    - Charite - Universitaetsmedizin Berlin, Campus Mitte
  - Blankenfelde-Mahlow, Germany, 15831
    - Recruiting
    - Dermatologische Gemeinschaftspraxis-Mahlow
  - Bochum, Germany, 44793
    - Recruiting
    - Hautarztpraxis Dr Niesmann und Dr Othlinghaus
  - Darmstadt, Germany, 64283
    - Recruiting
    - Rosenpark Research GmbH
  - Dresden, Germany, 01307
    - Recruiting
    - Universitaetsklinikum Dresden
  - Duesseldorf, Germany, 40225
    - Recruiting
    - Heinrich-Heine-Universitaet Duesseldorf - Universitaetsklinikum Duesseldorf
  - Essen, Germany, 45174
    - Recruiting
    - Universitaetsklinikum Essen
  - Hamburg, Germany, 20246
    - Recruiting
    - Institute for Health Services Research in Dermatology and Nursing
  - Heidelberg, Germany, 69120
    - Recruiting
    - Universitaetsklinikum Heidelberg
  - Stuttgart, Germany, 70178
    - Recruiting
    - Hautarztpraxis Dres Leitz und Kollegen
  - Tuebingen, Germany, 72076
    - Recruiting
    - Universitaetsklinikum Tuebingen
  - Wuppertal, Germany, 42287
    - Recruiting
    - CentroDerm GmbH
Greece
- - Athens, Greece, 11521
    - Recruiting
    - Athens Naval Hospital
  - Athens, Greece, 12462
    - Recruiting
    - University General Hospital ATTIKON
  - Athens, Greece, 16121
    - Recruiting
    - Andreas Syngros Hospital Of Venereal And Dermatological Diseases
  - Athens, Greece, 11527
    - Recruiting
    - Thoracic General Hospital Of Athens Sotiria
  - Ioannina, Greece, 45500
    - Recruiting
    - University General Hospital of Ioannina
  - Larissa, Greece, 41110
    - Recruiting
    - General University Hospital of Larissa
  - Thessaloniki, Greece, 56403
    - Recruiting
    - Papageorgiou General Hospital
Hungary
- - Veszprem, Hungary, 8200
    - Recruiting
    - Medmare Bt
Italy
- - Chieti, Italy, 66100
    - Recruiting
    - Universita degli Studi Gabriele D Annunzio di Chieti e Pescara
  - Milano, Italy, 20122
    - Recruiting
    - Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
  - Perugia, Italy, 06156
    - Recruiting
    - Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia
  - Roma, Italy, 00161
    - Recruiting
    - Azienda Ospedaliera Policlinico Umberto I
  - Torino, Italy, 10126
    - Recruiting
    - Azienda Ospedaliera Citta Della Salute E Della Scienza Di Torino
Japan
- Aichi
  - Nagakute-shi, Aichi, Japan, 480-1195
    - Recruiting
    - Aichi Medical University Hospital
  - Nagoya-shi, Aichi, Japan, 457-8510
    - Recruiting
    - Japan Community Healthcare Organization Chukyo Hospital
  - Nagoya-shi, Aichi, Japan, 467-8602
    - Recruiting
    - Nagoya City University Hospital
  - Nagoya-shi, Aichi, Japan, 464-0821
    - Recruiting
    - Central Clinic
- Fukuoka
  - Fukuoka-shi, Fukuoka, Japan, 814-0180
    - Recruiting
    - Fukuoka University Hospital
  - Fukuoka-shi, Fukuoka, Japan, 819-0373
    - Recruiting
    - Matsuo Clinic
- Fukushima
  - Fukushima-shi, Fukushima, Japan, 960-1295
    - Recruiting
    - Fukushima Medical University Hospital
- Hokkaido
  - Asahikawa-shi, Hokkaido, Japan, 070-8610
    - Recruiting
    - Asahikawa City Hospital
- Ibaraki
  - Inashiki-gun, Ibaraki, Japan, 300-0395
    - Recruiting
    - Tokyo Medical University Ibaraki Medical Center
- Ishikawa
  - Nonoichi-shi, Ishikawa, Japan, 921-8801
    - Recruiting
    - Kaji Dermatology Clinic
- Iwate
  - Morioka-shi, Iwate, Japan, 020-8505
    - Recruiting
    - Iwate Medical University Uchimaru Medical Center
- Kagawa
  - Marugame-shi, Kagawa, Japan, 763-0074
    - Recruiting
    - Takeoka Dermatology Clinic
- Kanagawa
  - Kawasaki-shi, Kanagawa, Japan, 211-8533
    - Recruiting
    - Nippon Medical School Musashikosugi Hospital
- Kyoto
  - Kyoto-shi, Kyoto, Japan, 602-8566
    - Recruiting
    - University Hospital Kyoto Prefectural University of Medicine
  - Kyoto-shi, Kyoto, Japan, 607-8062
    - Recruiting
    - Rakuwakai Otowa Hospital
- Osaka
  - Izumiotsu-shi, Osaka, Japan, 595-0025
    - Recruiting
    - Mochida Dermatology Clinic
- Tochigi
  - Shimotsuga-gun, Tochigi, Japan, 321-0293
    - Recruiting
    - Dokkyo Medical University Hospital
- Tokyo
  - Itabashi-ku, Tokyo, Japan, 173-8606
    - Recruiting
    - Teikyo University Hospital
  - Itabashi-ku, Tokyo, Japan, 173-8610
    - Recruiting
    - Nihon University Itabashi Hospital
Korea, Republic of
- - Ansansi, Gyeonggido, Korea, Republic of, 15355
    - Recruiting
    - Korea University Ansan Hospital
  - Incheon, Korea, Republic of, 21431
    - Recruiting
    - The Catholic University of Korea Incheon St Marys Hospital
  - Seoul, Korea, Republic of, 08308
    - Recruiting
    - Korea University Guro Hospital
  - Seoul, Korea, Republic of, 03080
    - Recruiting
    - Seoul National University Hospital
  - Seoul, Korea, Republic of, 05505
    - Recruiting
    - Asan Medical Center
  - Seoul, Korea, Republic of, 04564
    - Recruiting
    - National Medical Center
Latvia
- - Riga, Latvia, 1003
    - Recruiting
    - Outpatient Clinic Veselibas Centrs 4
  - Riga, Latvia, LV-1013
    - Recruiting
    - Outpatient clinic Veselibascentrs 4
  - Talsi, Latvia, 3201
    - Recruiting
    - Smite Aija practice in dermatology and venerology
Netherlands
- - Born, Netherlands, 6121 XK
    - Completed
    - PreCare Trial and Recruitment
Poland
- - Gdansk, Poland, 80-280
    - Recruiting
    - AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy
  - Katowice, Poland, 40-611
    - Recruiting
    - Centrum Medyczne Angelius Provita
  - Lublin, Poland, 20-080
    - Recruiting
    - Centrum Zdrowia i Urody Maxxmed
  - Malbork, Poland, 82-200
    - Recruiting
    - Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Spzoo
  - Nowa Sol, Poland, 67-100
    - Recruiting
    - Twoja Przychodnia NCM
  - Poznan, Poland, 61-293
    - Recruiting
    - Twoja Przychodnia PCM
  - Szczecin, Poland, 71-500
    - Recruiting
    - Twoja Przychodnia Scm
  - Tarnow, Poland, 33-100
    - Recruiting
    - Alergo-Med Specjalistyczna Przychodnia Lekarska Spzoo
  - Warszawa, Poland, 02-962
    - Recruiting
    - Royalderm Agnieszka Nawrocka
  - Wroclaw, Poland, 50-450
    - Recruiting
    - Dermatologiczna Praktyka Lekarska Michal Torz Dermaceum Centrum Badan Klinicznych
Portugal
- - Lisboa, Portugal, 1998-018
    - Recruiting
    - Hospital Cuf Descobertas
  - Lisboa, Portugal, 1500-458
    - Recruiting
    - Hospital Lusiadas Lisboa
  - Matosinhos, Portugal, 4464-513
    - Recruiting
    - Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano
  - Porto, Portugal, 4099-001
    - Recruiting
    - Centro Hospitalar Universitario do Porto, EPE - Hospital de Santo Antonio
Puerto Rico
- - San Juan, Puerto Rico, 00909
    - Recruiting
    - Clinical Research of Puerto Rico
Slovakia
- - Banska Bystrica, Slovakia, 975 17
    - Recruiting
    - Fakultna Nemocnica s poliklinikou F D Roosevelta Banska Bystrica
  - Bratislava, Slovakia, 851 01
    - Recruiting
    - Derma therapy, spol s ro
  - Svidnik, Slovakia, 089 01
    - Recruiting
    - Sanare spol sro
  - Topolcany, Slovakia, 955 01
    - Recruiting
    - Kaderma Majtan, sro
  - Trnava, Slovakia, 917 75
    - Recruiting
    - Fakultna nemocnica Trnava
Spain
- - Madrid, Spain, 28031
    - Recruiting
    - Hospital Universitario Infanta Leonor
  - Madrid, Spain, 28006
    - Recruiting
    - Hospital Universitario de la Princesa
- Andalucía
  - Cordoba, Andalucía, Spain, 14004
    - Recruiting
    - Hospital Universitario Reina Sofia
- Aragón
  - Zaragoza, Aragón, Spain, 50009
    - Recruiting
    - Hospital Universitario Miguel Servet
- Canarias
  - Las Palmas de Gran Canaria, Canarias, Spain, 35010
    - Recruiting
    - Hospital Universitario de Gran Canaria Doctor Negrin
- Cataluña
  - Badalona, Cataluña, Spain, 08916
    - Recruiting
    - Hospital Universitari Germans Trias i Pujol
  - Hospitalet de LLobregat, Cataluña, Spain, 08907
    - Recruiting
    - Hospital Universitari de Bellvitge
- Comunidad Valenciana
  - Valencia, Comunidad Valenciana, Spain, 46026
    - Terminated
    - Hospital Universitari I Politecnic La Fe
- Galicia
  - Pontevedra, Galicia, Spain, 36001
    - Recruiting
    - Hospital Clinico Universitario de Santiago
- Madrid
  - Pozuelo de Alarcon, Madrid, Spain, 28223
    - Recruiting
    - Hospital Universitario Quironsalud Madrid
Taiwan
- - Kaohsiung, Taiwan, 83301
    - Recruiting
    - Kaohsiung Chang Gung Memorial Hospital
  - Tainan, Taiwan, 70403
    - Recruiting
    - National Cheng Kung University Hospital
  - Taipei, Taiwan, 10002
    - Recruiting
    - National Taiwan University Hospital
  - Taipei, Taiwan, 11217
    - Recruiting
    - Taipei Veterans General Hospital
  - Taipei, Taiwan, 10449
    - Recruiting
    - Mackay Memorial Hospital Taipei Branch
  - Taoyuan, Taiwan, 33305
    - Recruiting
    - Linkou Chang Gung Memorial Hospital
United States
- Alabama
  - Birmingham, Alabama, United States, 35244
    - Recruiting
    - Cahaba Dermatology and Skin Health Center
- Arizona
  - Phoenix, Arizona, United States, 85032
    - Recruiting
    - Alliance Dermatology and Mohs Center
- California
  - Anaheim, California, United States, 92801
    - Terminated
    - Anaheim Clinical Trials
  - Fountain Valley, California, United States, 92708
    - Recruiting
    - First Oc Dermatology
  - Glendale, California, United States, 91203
    - Terminated
    - Kaiser Permanente - Glendale Medical Center
  - Long Beach, California, United States, 90805
    - Recruiting
    - Long Beach Research Institute
  - Los Angeles, California, United States, 90045
    - Recruiting
    - Dermatology Research Associates
  - Los Angeles, California, United States, 90027
    - Terminated
    - Kaiser Permanente Los Angeles Medical Center
  - Sherman Oaks, California, United States, 91403
    - Recruiting
    - Cura Clinical Research
- Colorado
  - Centennial, Colorado, United States, 80112
    - Recruiting
    - IMMUNOe Research Centers
- Florida
  - Boca Raton, Florida, United States, 33486
    - Recruiting
    - Skin Care Research Incorporated
  - Delray Beach, Florida, United States, 33484
    - Terminated
    - Palm Beach Dermatology Group
  - Homestead, Florida, United States, 33030
    - Recruiting
    - Global Research Associates
  - Miami, Florida, United States, 33175
    - Recruiting
    - Healthy Life Research
  - Miami Lakes, Florida, United States, 33014
    - Recruiting
    - Savin Medical Group LLC
  - Naples, Florida, United States, 34102
    - Recruiting
    - Kirsch Dermatology LLC
  - Orlando, Florida, United States, 32819
    - Terminated
    - Pure Skin Dermatology and Aesthetics
  - Saint Petersburg, Florida, United States, 33709
    - Terminated
    - Industrial Medicine Associates Ima Clinical Research Inc
  - Tampa, Florida, United States, 33606
    - Recruiting
    - Genesis Clinical Research LLC
- Idaho
  - Boise, Idaho, United States, 83706
    - Recruiting
    - Treasure Valley Medical Research
- Illinois
  - Chicago, Illinois, United States, 60611
    - Recruiting
    - DeNova Research
  - West Dundee, Illinois, United States, 60118
    - Recruiting
    - Dundee Dermatology
- Indiana
  - Plainfield, Indiana, United States, 46168
    - Recruiting
    - The Indiana Clinical Trials Center PC
- Maryland
  - Chevy Chase, Maryland, United States, 20815
    - Recruiting
    - Institute for Asthma and Allergy
  - Towson, Maryland, United States, 21204
    - Recruiting
    - Continental Clinical Solutions, LLC
- Michigan
  - Detroit, Michigan, United States, 48202
    - Recruiting
    - Henry Ford Health System
  - Flint, Michigan, United States, 48532
    - Recruiting
    - Onyx Clinical Research
- Missouri
  - Lee's Summit, Missouri, United States, 64064
    - Recruiting
    - Dermatology and Skin Cancer Center of Lees Summit
- Nevada
  - Las Vegas, Nevada, United States, 89106
    - Recruiting
    - Jubilee Clinical Research Inc
- New Hampshire
  - Portsmouth, New Hampshire, United States, 03801
    - Terminated
    - Allcutis Research, Llc - Portsmouth
- New Jersey
  - Cherry Hill, New Jersey, United States, 08034
    - Recruiting
    - Continental Clinical Solutions - Cherry Hill
- New York
  - Hartsdale, New York, United States, 10530
    - Recruiting
    - Industrial Medicine Associates Ima Clinical Research Inc
  - New York, New York, United States, 10075
    - Recruiting
    - Sadick Research Group
- North Carolina
  - Charlotte, North Carolina, United States, 28277
    - Recruiting
    - Onsite Clinical Solutions
  - Charlotte, North Carolina, United States, 28277
    - Recruiting
    - Dermatology Specialists of Charlotte
  - Wilmington, North Carolina, United States, 28405
    - Recruiting
    - Wilmington Dermatology Center
  - Winston-Salem, North Carolina, United States, 27103
    - Recruiting
    - The Skin Surgery Center for Clinical Research
- Ohio
  - Boardman, Ohio, United States, 44512
    - Recruiting
    - Optima Research
  - Columbus, Ohio, United States, 43213
    - Recruiting
    - ClinOhio Research Services
- Oklahoma
  - Oklahoma City, Oklahoma, United States, 73118
    - Recruiting
    - Unity Clinical Research
  - Tulsa, Oklahoma, United States, 74132
    - Recruiting
    - Dermatology Research Center of Oklahoma, PLLC
  - Tulsa, Oklahoma, United States, 74137
    - Recruiting
    - Essential Medical Research LLC
- Oregon
  - Portland, Oregon, United States, 97239
    - Terminated
    - Oregon Health and Science University
- Pennsylvania
  - Sugarloaf, Pennsylvania, United States, 18249
    - Recruiting
    - DermDox Dermatology, LLC
- Tennessee
  - Hermitage, Tennessee, United States, 37076
    - Recruiting
    - Cumberland Skin Center
- Texas
  - Dallas, Texas, United States, 75230
    - Recruiting
    - Dermatology Treatment and Research Center PA
  - The Woodlands, Texas, United States, 77380
    - Recruiting
    - The Woodlands Dermatology Associates
- Virginia
  - Lynchburg, Virginia, United States, 24501
    - Recruiting
    - Education and Research Foundation Inc
- Washington
  - Mill Creek, Washington, United States, 98012
    - Recruiting
    - Frontier Derm Partners
- West Virginia
  - Morgantown, West Virginia, United States, 26505
    - Recruiting
    - West Virginia Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Description

Inclusion Criteria:

Age ≥ 18 years with a diagnosis of AD according to the AAD Consensus Criteria (2014) present for at least 12 months
History of inadequate response to TCS (Topical Corticosteroid) of medium to higher potency within 6 months (with or without topical calcineurin inhibitors [TCI]).
EASI score ≥16
vIGA-AD score ≥3
≥10% body surface area (BSA) of AD involvement
Worst pruritus numerical rating scale ≥ 4

Exclusion Criteria:

Treatment with a biological product within 12 weeks or 5 half-lives, whichever is longer, prior to Day 1
Treatment with any of the following medications or therapies within 4 weeks or 5 half-lives, whichever is longer, prior to Day 1:
- Systemic corticosteroids
- Systemic immunosuppressants
- Phototherapy
- Janus kinase inhibitors
Treatment with any of the following medications or therapies within 1 week, prior to Day 1:
- TCS of any potency
- TCI
- Topical phosphodiesterase type 4 inhibitors
- Other topical immunosuppressive agents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Interventional Model: Parallel Assignment
Masking: Double

Number of Arms

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Arm A Rocatinlimab Dose 1 every 4 weeks (Q4W) + loading dose at Week 2	Drug: Rocatinlimab Participants will receive Rocatinlimab subcutaneously. Other Names: AMG 451
Experimental: Arm B Rocatinlimab Dose 2 Q4W + loading dose at Week 2	Drug: Rocatinlimab Participants will receive Rocatinlimab subcutaneously. Other Names: AMG 451
Placebo Comparator: Arm C Placebo Q4W+ loading dose at Week 2	Drug: Placebo Participants will receive a placebo subcutaneously.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Achievement of a Validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD) score of 0 or 1 with ≥2 point reduction from baseline at Week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of ≥75% reduction from baseline in Eczema Area and Severity Index (EASI) score at Week 24 Time Frame: Baseline, Week 24	Baseline, Week 24

Secondary Outcome Measures

Outcome Measure	Time Frame
Achievement of ≥75% reduction from baseline in EASI score at Week 16 Time Frame: Baseline, Week 16	Baseline, Week 16
Achievement of a ≥ 4-point reduction from baseline in weekly average of daily worst pruritus numerical rating scale (NRS) score at week 16 in subjects with baseline weekly average of daily worst pruritus NRS score ≥ 4 Time Frame: Baseline, Week 16	Baseline, Week 16
Achievement of a ≥ 4-point reduction from baseline in weekly average of daily worst pruritus NRS score at week 24 in subjects with baseline weekly average of daily worst pruritus NRS score ≥ 4 Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of ≥90% reduction from baseline in EASI score at Week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Change from baseline in weekly average of daily AD skin pain NRS score at week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of ≥ 4-point reduction from baseline in DLQI score at week 24 in subjects with baseline DLQI score ≥ 4 Time Frame: Baseline, Week 24	Baseline, Week 24
Change from baseline in DLQI score at week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of ≥ 4-point reduction from baseline in POEM score at week 24 in subjects with baseline POEM score ≥ 4 Time Frame: Baseline, Week 24	Baseline, Week 24
Change from baseline in POEM score at week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Change from baseline in weekly average of daily AD skin pain NRS score at week 16 Time Frame: Baseline, Week 16	Baseline, Week 16
Change from baseline in weekly average of daily sleep disturbance NRS score at week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of Hospital Anxiety and Depression Scale (HADS)-anxiety subscale score < 8 at week 24 in subjects with baseline HADS-anxiety subscale score ≥ 8 Time Frame: Baseline, Week 24	Baseline, Week 24
Change from baseline in HADS-anxiety subscale score at week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of HADS-depression subscale score < 8 at week 24 in subjects with baseline HADS-depression subscale score ≥ 8 Time Frame: Baseline, Week 24	Baseline, Week 24
Change from baseline in HADS-depression subscale score at week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of Facial AD Severity Score of Clear at week 24 for subjects with facial AD at baseline Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of Hand AD Severity Score of Clear at week 24 for subjects with hand AD at baseline Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of Genital AD Severity Score of Clear at week 24 for subjects with genital AD at baseline Time Frame: Baseline, Week 24	Baseline, Week 24
Change from baseline in weekly average of daily worst pruritus NRS score at week 16 Time Frame: Baseline, Week 16	Baseline, Week 16
Change from baseline in weekly average of daily worst pruritus NRS score at week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Change from baseline in SCORing Atopic Dermatitis (SCORAD) itch visual analogue scale (VAS) score at week 16 Time Frame: Baseline, Week 16	Baseline, Week 16
Change from baseline in SCORAD itch VAS score at week 24 Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of ≥ 8.7-point reduction from baseline in SCORAD score at week 24 in participants with baseline SCORAD score ≥ 8.7 Time Frame: Baseline, Week 24	Baseline, Week 24
Achievement of a vIGA-AD score of 0 or 1 from baseline at week 16 Time Frame: Baseline, Week 16	Baseline, Week 16
Achieving vIGA-AD 1 response with presence of only barely perceptible erythema or vIGA-AD 0 response at week 24 Time Frame: Baseline, Week 24	Baseline, Week 24

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Amgen

Investigators

Study Director: MD, Amgen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

AmgenTrials clinical trials website

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 31, 2022

Primary Completion (Estimated)

January 6, 2025

Study Completion (Estimated)

March 30, 2025

Study Registration Dates

First Submitted

May 24, 2022

First Submitted That Met QC Criteria

May 31, 2022

First Posted (Actual)

June 1, 2022

Study Record Updates

Last Update Posted (Actual)

April 19, 2024

Last Update Submitted That Met QC Criteria

April 17, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

20210142

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.

IPD Sharing Time Frame

Data sharing requests relating to this study will be considered beginning 18 months after the study has ended and either 1) the product and indication have been granted marketing authorization in both the US and Europe or 2) clinical development for the product and/or indication discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for this study.

IPD Sharing Access Criteria

Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling. Requests are reviewed by a committee of internal advisors. If not approved, a Data Sharing Independent Review Panel will arbitrate and make the final decision. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the URL below.

IPD Sharing Supporting Information Type

STUDY_PROTOCOL
SAP
ICF
CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atopic Dermatitis

Catalysis SL

Completed

Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children

Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis and Related Conditions | Atopic Dermatitis \(AD\)

Serbia
Jacob Pontoppidan Thyssen
The Novo Nordic Foundation

Recruiting

Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis

Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis Flare

Denmark
Shaperon

Recruiting

Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis of Scalp

United States
University of California, San Francisco
Sanofi; Regeneron Pharmaceuticals

Recruiting

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis and Related Conditions

United States
Pfizer

Active, not recruiting

A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Eczema | Atopic Dermatitis | Eczema, Atopic | Atopic Dermatitis, Unspecified

United States, Canada, Czechia, Poland
Amgen

Completed

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic Dermatitis

Canada, United States, Japan
Hadassah Medical Organization

Unknown

Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis

ATOPIC DERMATITIS
Sanofi

Completed

Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China (BALISTAD-CN)

Atopic Dermatitis | Dermatitis Atopic

China
Sanofi

Completed

A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries (AD-impaCT)

Dermatitis Atopic

Saudi Arabia, Kuwait, United Arab Emirates
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis Research Network

Completed

Atopic Dermatitis (AD) and Food Allergy

Atopic Dermatitis (AD) | Non-atopic Healthy Controls

United States

Clinical Trials on Placebo

Galderma R&D

Completed

Effect of CD07805/47 Gel in Rosacea Flushing

Rosacea

Germany
SamA Pharmaceutical Co., Ltd

Unknown

Clinical Trials to Assess the Efficacy and Safety of HLIM

Acute Bronchitis | Acute Upper Respiratory Tract Infection

Korea, Republic of
National Institute on Drug Abuse (NIDA)

Completed

Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics

Cannabis Use

United States
AstraZeneca
Parexel; Spandauer Damm 130; 14050; Berlin, Germany

Completed

Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)

Male Subjects With Type II Diabetes (T2DM)

Germany
Heptares Therapeutics Limited

Completed

Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects (HTL0018318)

Pharmacokinetics | Safety Issues

United Kingdom
GlaxoSmithKline

Completed

A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United Kingdom, Netherlands
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Xuanwu Hospital, Beijing

Completed

Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets

Parkinson Disease

China
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects

Infections, Bacterial

United States
Italfarmaco

Completed

Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy

Becker Muscular Dystrophy

Netherlands, Italy
West Penn Allegheny Health System

Completed

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis

Asthma | Allergic Rhinitis

United States

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) (ROCKET-Ignite)

A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD)

Study Overview

Status

Conditions

Intervention / Treatment

Study Type

Enrollment (Estimated)

Phase

Contacts and Locations

Study Contact

Study Locations

Participation Criteria

Eligibility Criteria

Ages Eligible for Study

Accepts Healthy Volunteers

Description

Study Plan

How is the study designed?

Design Details

Number of Arms

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure

Time Frame

Secondary Outcome Measures

Outcome Measure

Time Frame

Collaborators and Investigators

Sponsor

Investigators

Publications and helpful links

Helpful Links

Study record dates

Study Major Dates

Study Start (Actual)

Primary Completion (Estimated)

Study Completion (Estimated)

Study Registration Dates

First Submitted

First Submitted That Met QC Criteria

First Posted (Actual)

Study Record Updates

Last Update Posted (Actual)

Last Update Submitted That Met QC Criteria

Last Verified

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

IPD Plan Description

IPD Sharing Time Frame

IPD Sharing Access Criteria

IPD Sharing Supporting Information Type

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Studies a U.S. FDA-regulated device product

Clinical Trials on Atopic Dermatitis

Clinical Trials on Placebo

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations